Review Articles

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Authors:

Abstract

Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

Keywords:

transcatheter aortic valve replacementTAVRsurgical aortic valve replacementSAVRexpandable valves
  • Year: 2017
  • Volume: 13 Issue: 3
  • Page/Article: 126-131
  • DOI: 10.14797/mdcj-13-3-126
  • Published on 1 Jul 2017
  • Peer Reviewed